MIT Tech Review
Jun 21, 2023
UPSIDE Foods wins regulatory approval to sell lab-grown meat in the US
UPSIDE Foods’ cell-cultivated chicken.

UPSIDE Foods has secured the trifecta of regulatory approvals needed to take its cell-cultivated chicken commercial.

  • “No Questions” Letter from FDA — November 2022
    • After rigorous evaluation of UPSIDE’s products and processes, the FDA issued a “No Questions” Letter (NQL).
  • USDA Label Approval — June 2023
    • UPSIDE received a USDA “label approval,” showing that it demonstrated full compliance with all pre-market requirements for labeling. This includes the label, the name of the product, ingredient statement, and handling instructions, all of which were and determined by the USDA to be truthful and not misleading.
  • USDA Grant of Inspection (GOI) — June 2023
    • Receiving a GOI from USDA means that UPSIDE has met the applicable federal requirements and standards to operate as a meat establishment and is allowed to process, package, and sell its cultivated chicken in the United States under the inspection of USDA’s Food Safety and Inspection Service.

With clearance to begin commercial production, UPSIDE can continue scaling its facilities and supply chains. Per the company, UPSIDE’s cultivated chicken will soon be available to the public for the first time at San Francisco’s Bar Crenn, prepared by 3-Michelin Star chef Dominique Crenn. Chef Crenn is a friend and partner of UPSIDE’s and a long-time champion of sustainable food systems.

Check out media coverage across Bloomberg, MIT Tech ReviewTechCrunch, and more.